Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
61,032,652
-
Shares change
-
+6,332,058
-
Total reported value, excl. options
-
$1,829,399,090
-
Value change
-
+$194,997,573
-
Put/Call ratio
-
113%
-
Number of buys
-
89
-
Number of sells
-
-95
-
Price
-
$29.99
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2014
212 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q2 2014.
IMPAX LABORATORIES INC - COM (IPXL) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,032,652 shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5,415,600 shares), BlackRock Fund Advisors (4,682,088 shares), VANGUARD GROUP INC (4,402,564 shares), FMR LLC (3,776,532 shares), Invesco Ltd. (3,193,231 shares), State Street Corp (2,348,197 shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2,192,509 shares), BlackRock Institutional Trust Company, N.A. (1,892,266 shares), JENNISON ASSOCIATES LLC (1,721,415 shares), and Ameriprise Financial Inc (1,574,550 shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.